BLOG

Coronavirus disease 2019


COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

image

ENSO hosted 5th General Assembly of DARE2X project in A Coruña


During the 15th and 16th of October, ENSO hosted 5th General Assembly of the DARE2X project in A Coruña, with the participation of the whole consortium: Danish Teknologisk Institut (DTI), Hulteberg Chemistry & Engineering AB, Kemijski inštitut – National Institute of Chemistry, The University of Liverpool and LOMARTOV S.L.

In DARE2X, funded by the Horizon Europe programme, we are using the novel sorption-enhanced plasma catalytic Power-to-X technology to achieve decentralised production of ammonia (NH3) from renewable energies. As the project progresses, key decisions are being made on the large-scale production and validation of the sorption unit, as well as on the large-scale design of the plasma reactor.

Read More

image

EU-funded project HEROES kicks off in May 2021 –

By - Uncategorized

The EU-funded project “Hybrid EneRgy stOragE Stations” (HEROES) has officially kicked off on 1st May 2021. 100% Funded under EU Horizon 2020 Research and Innovation programm with €4,1 MN, HEROES aims at supporting the increased uptake of electric vehicles in Europe, thanks to the development and implementation of more efficient charging stations. Read More